{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8254345", "DateCompleted": {"Year": "1994", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "04"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "56", "Issue": "9", "PubDate": {"Year": "1993", "Month": "Sep"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "A screen for inhibitors of DNA recombination: identification of two new spirostanol glycosides from Chamaedorea linearis.", "Pagination": {"StartPage": "1451", "EndPage": "1458", "MedlinePgn": "1451-8"}, "Abstract": {"AbstractText": ["Two new glycosides have been isolated from the MeOH extract of the stem wood and stem bark of an Ecuadorian plant Chamaedorea linearis, and their structures have been determined by spectroscopic means and X-ray analysis of the aglycone to be 1-O-[beta-L-fucopyranosyl-(4'-sulfate)]-25R,5 alpha-spirostane-1 beta, 3 beta-diol [1]) and 1-O-[beta-L-fucopyranosyl-(4'-sulfate)]-25R,5 alpha-spirostane-1 alpha, 3 beta-diol [2]. These compounds were identified in a screen for inhibitors of recombinational DNA repair. Cytotoxic activity was also demonstrated."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomolecular Discovery, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939."}], "LastName": "Patil", "ForeName": "A D", "Initials": "AD"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Baures", "ForeName": "P W", "Initials": "PW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Eggleston", "ForeName": "D S", "Initials": "DS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Faucette", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hemling", "ForeName": "M E", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Westley", "ForeName": "J W", "Initials": "JW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Johnson", "ForeName": "R K", "Initials": "RK"}], "GrantList": [{"GrantID": "CA-50771", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Spirostans"}, {"RegistryNumber": "151589-15-0", "NameOfSubstance": "1-O-(fucopyranosyl-(4'-sulfate))-5-spirostane-1,3-diol"}, {"RegistryNumber": "151589-16-1", "NameOfSubstance": "1-O-(2',3'-diacetylfucopyranosyl-(4'-sulfate))-5-spirostan-1-ol 3-acetate"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Crystallography, X-Ray"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "DNA"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Damage"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Repair"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Ecuador"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia L1210"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Recombination, Genetic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Saccharomyces cerevisiae"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Spirostans"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1993", "Month": "9", "Day": "1"}, {"Year": "1993", "Month": "9", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1993", "Month": "9", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8254345", "10.1021/np50099a003"]}}]}